» Articles » PMID: 20378577

Increased MYC Gene Copy Number Correlates with Increased MRNA Levels in Diffuse Large B-cell Lymphoma

Overview
Journal Haematologica
Specialty Hematology
Date 2010 Apr 10
PMID 20378577
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Translocations involving the MYC gene and increased MYC mRNA levels are associated with poor outcome in diffuse large B-cell lymphoma. However, the presence of increased MYC gene copy number and/or polysomy of chromosome 8 have not been previously described.

Design And Methods: Utilizing dual color chromogenic in situ hybridization, we investigated MYC gene copy and chromosome 8 centromere numbers in 52 cases of diffuse large B-cell lymphoma. Cases were divided into those with "increased" or "not increased" MYC gene copy number for comparison with MYC mRNA levels, Ki-67 values, and survival.

Results: Increased MYC gene copy number was present in 38% of cases. Overall, the average MYC mRNA level was 2398 (range, 342 - 9783) and the percentage of nuclei positive for Ki-67 was 57.5% (range, 20-87%). Within the group with increased MYC copy number, the MYC mRNA values ranged from 816 to 5912 (average, 2843) and the Ki-67 values ranged from 23% to 83% (average, 57%). Within the group with not increased MYC copy number, MYC mRNA values ranged from 342 to 9783 (average, 2118) and the Ki-67 values ranged from 20% to 87% (average, 58%). There was a statistically significant relationship between increased MYC gene copy number and increased MYC mRNA (P=0.034) and a trend toward a relationship between increased mRNA and higher Ki-67 values.

Conclusions: This is the first report that low level copy number increases are common in diffuse large B-cell lymphoma and that these changes correlate with MYC mRNA in a statistically significant manner. MYC copy number changes are an additional possible molecular mechanism that may result in increased mRNA and, likely, high proliferation and poor outcome.

Citing Articles

Chromogenic mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS.

Papaleo N, Molina-Alvarez A, Onieva R, Fuertes D, Sanchez-Gonzalez B, Riera X Cancers (Basel). 2024; 16(13).

PMID: 39001439 PMC: 11240605. DOI: 10.3390/cancers16132378.


MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B-cell lymphoma patients.

Wang Y, Liu D, Zhang X, Zhang M, Li S, Feng X Cancer Med. 2023; 12(18):18568-18577.

PMID: 37641492 PMC: 10557898. DOI: 10.1002/cam4.6463.


Development of a Prognostic Scoring System using MYC Expression and Soluble Interleukin Receptor -2 level for Diffuse Large B-cell Lymphoma.

Suzuki S, Kuwamoto S, Kawamura K, Matsushita M, Motokura T, Hosoda Y Yonago Acta Med. 2023; 66(1):56-66.

PMID: 36820285 PMC: 9937959. DOI: 10.33160/yam.2023.02.007.


Altered pathways and targeted therapy in double hit lymphoma.

Zhuang Y, Che J, Wu M, Guo Y, Xu Y, Dong X J Hematol Oncol. 2022; 15(1):26.

PMID: 35303910 PMC: 8932183. DOI: 10.1186/s13045-022-01249-9.


Assessment of MYC/PTEN Status by Gene-Protein Assay in Grade Group 2 Prostate Biopsies.

Salles D, Vidotto T, Faisal F, Tosoian J, Guedes L, Muranyi A J Mol Diagn. 2021; 23(8):1030-1041.

PMID: 34062284 PMC: 8491088. DOI: 10.1016/j.jmoldx.2021.05.006.


References
1.
Simonsson T, Pecinka P, Kubista M . DNA tetraplex formation in the control region of c-myc. Nucleic Acids Res. 1998; 26(5):1167-72. PMC: 147388. DOI: 10.1093/nar/26.5.1167. View

2.
Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M . A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev. 1994; 8(4):465-80. DOI: 10.1101/gad.8.4.465. View

3.
Pienkowska-Grela B, Witkowska A, Grygalewicz B, Rymkiewicz G, Rygier J, Woroniecka R . Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma. Cancer Genet Cytogenet. 2005; 156(2):114-21. DOI: 10.1016/j.cancergencyto.2004.04.009. View

4.
Kouzine F, Levens D . Supercoil-driven DNA structures regulate genetic transactions. Front Biosci. 2007; 12:4409-23. DOI: 10.2741/2398. View

5.
Wongchaowart N, Kim B, Hsi E, Swerdlow S, Tubbs R, Cook J . t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas. J Cutan Pathol. 2006; 33(4):286-92. DOI: 10.1111/j.0303-6987.2006.00459.x. View